Review Note

Last Update: 07/28/2024 06:33 PM

Current Deck: Block I::Quiz 2::Week 3::i. Tyrosine Kinase Receptors

Published

Fields:

Text
{{c1::Tocilizumab}} and {{c1::sarilumab}} and {{c1::humira}} are antibodies to cytokine ligands that play a role in TK-AR signaling pathways thus they are often used to treat autoimmune/inflammatory diseases
Extra
Source
Image

Pronunciation

Suggested Changes:

Deck Changes (Suggestion to move the Note to the following Deck):

Field Changes:

Tag Changes: